ApoER2 Antibodies

Santa Cruz Biotechnology provides a broad selection of ApoER2 monoclonal antibodies for research focused on understanding ApoER2 protein function. ApoER2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ApoER2, a member of the low-density lipoprotein receptor family, plays a crucial role in neuronal signaling and development. Research has shown that ApoER2 significantly influences synaptic plasticity regulation and participates in neuroprotection processes. ApoER2 also demonstrates important functions in modulating lipid metabolism pathways. Understanding ApoER2 mechanisms and pathways continues to reveal new insights about neurological disorders. Ongoing research into ApoER2 functions helps identify potential therapeutic targets for various neurological conditions. Current studies examining ApoER2 expression patterns and interactions advance our knowledge of brain development and function. Santa Cruz Biotechnology monoclonal antibodies for ApoER2 research support scientists worldwide in advancing neuroscience discoveries and potential therapeutic developments.